National Center for Advancing Translational Sciences logo
Program

Rare Diseases Clinical Research Network (RDCRN)

Funds consortiums across multiple sites to study many rare diseases and improve trial coordination.

National Center for Advancing Translational SciencesUnited StatesCooperative agreement

The Rare Diseases Clinical Research Network is a federally mandated NCATS program that supports clinical research across more than 280 rare diseases. It is organized around multi-institution consortia at global clinical sites and is co-funded by NCATS with ten other NIH institutes, sometimes with help from patient advocacy organizations.

The main mechanism is the U54 cooperative agreement, with U…

Max award—
Realistic median—
Success rate—
Decision time—

No upcoming rounds verified. Cadence: Multiple per year.

Last verified: 29 May 2026Source: ncats.nih.gov